Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 7;20(1):275.
doi: 10.1186/s12893-020-00939-w.

Can thyroidectomy be considered safe in obese patients? A retrospective cohort study

Gian Luigi Canu  1 , Fabio Medas  2 , Federico Cappellacci  2 , Michele Guido Podda  2 , Giorgio Romano  3 , Enrico Erdas  2 , Pietro Giorgio Calò  2
Affiliations

Can thyroidectomy be considered safe in obese patients? A retrospective cohort study

Gian Luigi Canu et al. BMC Surg. .

Abstract

Background: Obesity is a growing public health concern in most western countries. More and more patients with high body mass index (BMI) are undergoing surgical procedures of all kinds and, in this context, obese patients are undergoing thyroid surgery more than ever before. The aim of the present study was to evaluate whether thyroidectomy can be considered safe in obese patients.

Methods: Patients undergoing thyroidectomy in our Unit between January 2014 and December 2018 were retrospectively analysed. Patients were divided into two groups: those with BMI < 30 kg/m2 were included in Group A, while those with BMI ≥ 30 kg/m2 in Group B. Univariate analysis was performed to compare these two groups. Moreover, multivariate analyses were performed to evaluate whether the BMI value (considered in this case as a continuous variable) had a significant role in the development of each individual postoperative complication.

Results: A total of 813 patients were included in this study: 31 (3.81%) were underweight, 361 (44.40%) normal-weight, 286 (35.18%) overweight, 94 (11.57%) obese and 41 (5.04%) morbidly obese. Six hundred and seventy-eight patients were included in Group A and 135 in Group B. At univariate analysis, the comparison between the two groups, in terms of operative time and thyroid weight resulted in statistically significant results (P = 0.001, P = 0.008; respectively). These features were significantly higher in Group B than in Group A. About postoperative stay and complications, no statistically significant difference was found between the two groups. At multivariate analyses, only the development of cervical haematoma was statistically significantly correlated to the BMI value. Patients with high BMI had a lower risk of cervical haematoma (P = 0.045, OR 0.797, 95% CI 0.638-0.995).

Conclusions: This study showed that obesity, in the field of thyroid surgery, is not associated with any increase of postoperative complications. Thus, it is possible to conclude that thyroidectomy can be performed safely in obese patients. Our result about operative times had no clinical significance.

Keywords: BMI; Body mass index; Complications; Endocrine surgery; Obesity; Thyroidectomy.

PubMed Disclaimer

Conflict of interest statement

Pietro Giorgio Calò is a member of the editorial board of this journal. The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Box plot representing the difference in terms of operative times between the two groups
Fig. 2
Fig. 2
Forest plot representing the impact of BMI on the development of each individual postoperative complication
See this image and copyright information in PMC

References

    1. Global BMI Mortality Collaboration, Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, Berrington de Gonzalez A, Cairns BJ, Huxley R et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. The Lancet. 2016;388:776–786. doi: 10.1016/S0140-6736(16)30175-1. - DOI - PMC - PubMed
    1. World Health Organization (WHO), Obesity and overweight. https://www.who.int/mediacentre/factsheets/fs311/en/. Accessed 7 Feb 2020.
    1. Teoh SL, Das S. Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment. Tumour Biol. 2016;37:14363–14380. doi: 10.1007/s13277-016-5357-7. - DOI - PubMed
    1. Harari A, Endo B, Nishimoto S, Ituarte PH, Yeh MW. Risk of advanced papillary thyroid cancer in obese patients. Arch Surg. 2012;147:805–811. doi: 10.1001/archsurg.2012.713. - DOI - PubMed
    1. Trésallet C, Seman M, Tissier F, Buffet C, Lupinacci RM, Vuarnesson H, Leenhardt L, Menegaux F. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices. Surgery. 2014;156:1145–1152. doi: 10.1016/j.surg.2014.04.020. - DOI - PubMed